[Ãëàâíàÿ/Ïîèñê] [Ïðîèçâîäèòåëè] [Ìîñêâà] [Ñ-Ïá] [Äðóãèå] [Îáùèé] [Çàÿâêè] [Âûáîðêà]

Öåíû íà ÍÀÇÈÂÈÍ ÊÀÏËÈ ÍÀÇ - ÍÓÐÎÔÅÍ ÔÎÐÒÅ 400ÌÃ ÒÀÁË.Ï/Î ¹12

Ïðîäàâåö: ÃÐÀÍÄ ÊÀÏÈÒÀË (Ìîñêâà,(495) 258-34-28)

ÍàèìåíîâàíèåÏðîèçâîäèòåëüÖåíà $Öåíà ðóá
ÍÀÇÈÂÈÍ ÊÀÏËÈ ÍÀÇ. ÔË.Ñ ÊÐÛØÊ.ÏÈÏÅÒ. 0,01% 5ÌËE.MERCK87.85
ÍÀÇÈÂÈÍ ÊÀÏËÈ ÍÀÇ.ÔË. 0,025% 10ÌËE.MERCK82.86
ÍÀÇÈÂÈÍ ÊÀÏËÈ ÍÀÇ.ÔË. 0,025% 10ÌËE.MERCK84.72
ÍÀÇÈÂÈÍ ÊÀÏËÈ ÍÀÇÀË. ÔË.0,05% 10ÌËE.MERCK78.78
ÍÀÇÎË ÀÄÂÀÍÑ ÑÏÐÅÉ ÍÀÇ. 0,05% 30ÌË ÔËÀÊ.INSTITUTO DE ANGELI136.36
ÍÀÇÎË ÀÄÂÀÍÑ ÑÏÐÅÉ ÍÀÇ. 0,05% 30ÌË ÔËÀÊ.INSTITUTO DE ANGELI136.47
ÍÀÇÎË ÁÝÁÈ ÊÀÏËÈ ÍÀÇ. 0,125% 15ÌË ÔËÀÊ.-ÊÀÏ.ÏËÀÑÒ.INSTITUTO DE ANGELI86.92
ÍÀÇÎË ÊÈÄÑ ÑÏÐÅÉ ÍÀÇ. 0,25% 15ÌË ÔËÀÊ.Ñ ÐÀÑÏÛË.(Ä\ÄÅÒÅÉ)INSTITUTO DE ANGELI85.88
ÍÀÇÎË ÑÏÐÅÉ ÍÀÇ. 0,05% 15ÌË ÔËÀÊ.INSTITUTO DE ANGELI81
ÍÀÇÎË ÑÏÐÅÉ ÍÀÇ.ÔË. 0,05% 30ÌËINSTITUTO DE ANGELI120.43
ÍÀÇÎÍÅÊÑ 50ÌÊÃ/ÄÎÇÀ 120 ÄÎÇ ÍÀÇ. ÑÏÐÅÉ"SCHERING-PLOUGH"710
ÍÀÉÇ ÃÅËÜ 1% -20Ã.DR.REDDY"S82.53
ÍÀÉÇ ÒÀÁ. 100ÌÃ ¹20DR.REDDY"S73.97
ÍÀÉÇ ÒÀÁ. 100ÌÃ ¹20DR.REDDY"S76.76
ÍÀÉÇ ÒÀÁ. ÄÈÑÏÅÐÃ. 50ÌÃ ¹20DR.REDDY"S35.54
ÍÀÉÇ ÒÀÁ. ÄÈÑÏÅÐÃ. 50ÌÃ ¹20DR.REDDY"S36.65
ÍÀÏÀËÜ×ÍÈÊÈ ËÀÒÅÊÑ.ÈÍÄ.ÓÏ. ¹5ÀÌÒ ÒÐÅÉÄ3.35
ÍÀÒÐÈß ÒÅÒÐÀÁÎÐÀÒ Ð-Ð 20% 30ÃÎÀÎ"ÒÂÅÐÑÊÀß ÔÀÐÌÀÖÅÂÒÈ×ÅÑÊÀß ÔÀÁÐÈÊÀ"6.1
ÍÀÒÐÈß ÒÅÒÐÀÁÎÐÀÒÀ (ÁÓÐÛ) Ð-Ð Â ÃËÈÖ. 20%, Ð-Ð 20% 30Ã"ÌÎÑÊÎÂÑÊÀß ÔÀÐÌÔÀÁÐÈÊÀ" ÎÀÎ6.1
ÍÀÒÐÈß ÒÈÎÑÓËÜÔÀÒ Ð-Ð Ä/ÈÍ.30%-10ÌË.ÀÌÏ.¹10"ÌÎÑÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ" ÔÃÓÏ ÈÌ. Í.À. ÑÅÌÀØÊÎ59.62
ÍÀÒÐÈß ÕËÎÐÈÄÀ ÈÇÎÒ Ð-Ð Ä/ÈÍ ÔË. 0,9% 200ÌËÝÑÊÎÌ ÍÏÊ ÎÀÎ15
ÍÀÒÐÈß ÕËÎÐÈÄÀ ÈÇÎÒ Ð-Ð Ä/ÈÍ ÔË. 0,9% 200ÌËÝÑÊÎÌ ÍÏÊ ÎÀÎ15
ÍÀÔÒÈÇÈÍ Ð-Ð 0,1% ÊÀÏËÈ ÏËÀÑÒÈÊ ÔË/ÊÀÏ. 15ÌË"ÑËÀÂßÍÑÊÀß ÀÏÒÅÊÀ" ÎÎÎ3.3
ÍÀÔÒÈÇÈÍ Ð-Ð 0,1% ÊÀÏËÈ ÔËÀÊÎÍ 10ÌË"ÑËÀÂßÍÑÊÀß ÀÏÒÅÊÀ" ÎÎÎ2.19
ÍÀÔÒÈÇÈÍ Ð-Ð 0,1% ÏËÀÑÒÈÊ ÔË/ÊÀÏ. 10ÌË"ÑËÀÂßÍÑÊÀß ÀÏÒÅÊÀ" ÎÎÎ3.17
ÍÀØÀÒÛÐÍÎ-ÀÍÈÑÎÂÛÅ ÊÀÏËÈ 25ÌË ÔËÀÊ.ÎÀÎ"ÒÂÅÐÑÊÀß ÔÀÐÌÀÖÅÂÒÈ×ÅÑÊÀß ÔÀÁÐÈÊÀ"6.55
ÍÀßÒÎÊÑ ÌÀÇÜ 20Ã ÒÓÁ.MEKOPHAR CHEMICAL PHARMACEUTICAL JOINT STOCK COMPANY72.95
ÍÅÁÈËÅÒ 5ÌÃ.ÒÀÁ.¹28BERLIN-CHEMIE/MENARINI GROUP736.37
ÍÅÁÈËÅÒ ÒÀÁ.5ÌÃ ¹14BERLIN-CHEMIE/MENARINI GROUP403.16
ÍÅÃÐÓÑÒÈÍ ÊÀÏÑ.425ÌÃ ¹30HEXAL PHARMA (ÎÒÑ)135.19
ÍÅÊÑÈÓÌ ÒÀÁ. Ï/Î 20ÌÃ ¹14ASTRA ZENECA800.51
ÍÅÊÑÈÓÌ ÒÀÁ. Ï/Î 20ÌÃ ¹7ASTRA ZENECA430.08
ÍÅÎÒÎÍ ËÈÎÔ. Ä/ÏÐÈÃ.Ð-ÐÀ 1Ã ÔËÀÊ. ¹1 Ñ ÐÀÑÒÂÎÐ.-ÂÎÄÀ Ä/ÈÍ. 50ÌË ¹1 Ñ ÊÀÏÅËÜÍ.ALFA-WASSERMANN SPA853.55
ÍÅÐÂÎ-ÂÈÒ 0,24 ¹100ÏÀÐÀÔÀÐÌ119
ÍÅÓËÅÏÒÈË ÊÀÏÑ.10ÌÃ ¹50HAUPT PHARMA LIVRON216.9
ÍÅÓËÅÏÒÈË Ð-Ð 4% 125ÌËNATTERMANN&CIE1939.94
ÍÈÇÎÐÀË 2% ÊÐÅÌ 15Ã Ä/ÍÀÐ.ÏÐÈÌ.JANSSEN PHARMACEUTICA242.12
ÍÈÇÎÐÀË ÒÀÁ.0.2 ¹10JANSSEN PHARMACEUTICA464.37
ÍÈÇÎÐÀË ÒÀÁ.0.2 ¹30JANSSEN PHARMACEUTICA1283.31
ÍÈÇÎÐÀË ØÀÌÏÓÍÜ 2% 25 ÌËJANSSEN PHARMACEUTICA252
ÍÈÊÎÐÅÒÒÅ ÆÅÂ.ÐÅÇ. 2ÌÃ ¹30MCNEIL171.87
ÍÈÊÎÒÈÍÎÂÀß Ê-ÒÀ 1% 1 ÌË ÀÌÏ. ¹10"ÌÎÑÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ" ÔÃÓÏ ÈÌ. Í.À. ÑÅÌÀØÊÎ14.52
ÍÈÊÎÒÈÍÎÂÀß Ê-ÒÀ 1% 1 ÌË ÀÌÏ. ¹10"ÌÎÑÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ" ÔÃÓÏ ÈÌ. Í.À. ÑÅÌÀØÊÎ14.52
ÍÈÊÎÒÈÍÎÂÀß Ê-ÒÀ ÒÀÁ. 0,05Ã ¹50"ÌÎÑÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ" ÔÃÓÏ ÈÌ. Í.À. ÑÅÌÀØÊÎ6.1
ÍÈÊÎÒÈÍÎÂÀß Ê-ÒÀ ÒÀÁË. 0,05 ¹50"ÈÐÁÈÒÑÊÈÉ ÕÔÇ"6.1
ÍÈÊÎÒÈÍÎÂÀß ÊÈÑËÎÒÀ 1% 1ÌË ¹10"ÎÐÃÀÍÈÊÀ" ÎÀÎ14.52
ÍÈÊÎÔËÅÊÑ ÌÀÇÜ ÄËß ÍÀÐ.ÏÐÈÌ.50Ã. ÒÓÁÀ ÀËÞÌ.REANAL111.52
ÍÈÌÅÑÈË ÃÐÀÍ. Ä/ÏÐÈÃ.ÑÓÑÏ. 100ÌÃ ¹30LABORATORI GUIDOTTI387.75
ÍÈÌÅÑÈË ÃÐÀÍ. Ä/ÏÐÈÃ.ÑÓÑÏ. 100ÌÃ ¹30LABORATORI GUIDOTTI465.01
ÍÈÌÓËÈÄ 100ÌÃ ÒÀÁ.ËÈÍÃÂ. ¹10PANACEA BIOTEC LTD51.64
ÍÈÌÓËÈÄ 100ÌÃ ÒÀÁ.ËÈÍÃÂ. Ä/ÐÀÑÑÀÑ. ¹20PANACEA BIOTEC LTD101.78
ÍÈÌÓËÈÄ 100ÌÃ ÒÀÁ.Õ30PANACEA BIOTEC LTD159.88
ÍÈÌÓËÈÄ 50ÌÃ/5ÌË ÑÓÑÏ. 60ÌËPANACEA BIOTEC LTD59.19
ÍÈÌÓËÈÄ ÃÅËÜ 1% 30ÃPANACEA BIOTEC LTD94.51
ÍÈÑÒÀÒÈÍ 250000 ÅÄ ÒÀÁ. Ï/Î ¹20"ÈÐÁÈÒÑÊÈÉ ÕÔÇ"9.08
ÍÈÑÒÀÒÈÍ 250000 ÅÄ ÒÀÁ. Ï/Î ¹20"ÈÐÁÈÒÑÊÈÉ ÕÔÇ"9.08
ÍÈÑÒÀÒÈÍ ÒÀÁ. 500000 ÅÄ.¹20"ÈÐÁÈÒÑÊÈÉ ÕÔÇ"14.5
ÍÈÑÒÀÒÈÍ ÒÀÁ. 500000 ÅÄ.¹20"ÈÐÁÈÒÑÊÈÉ ÕÔÇ"14.5
ÍÈÒÐÎÃËÈÖÅÐÈÍ ÊÀÏÑ. 1% 0,5ÌÃ ¹40"ËÞÌÈ" ÎÎÎ10.89
ÍÈÒÐÎÊÎÐ ÒÀÁ.ÏÎÄÚßÇ. 0,5Ìà ¹40 ( ÏÐÎÁÈÐÊÅ)ÔÀÐÌÑÒÀÍÄÀÐÒ-ËÅÊÑÐÅÄÑÒÂÀ32.15
ÍÈÒÐÎÊÑÎËÈÍ ÒÀÁ Ï/Î 0,05Ã ¹50"ÈÐÁÈÒÑÊÈÉ ÕÔÇ"29.89
ÍÈÒÐÎÊÑÎËÈÍ ÒÀÁ.Ï/Î 0,05Ã. ¹50ÒÀÒÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ ÎÀÎ29.89
ÍÈÒÐÎÊÑÎËÈÍ-ÓÁÔ 0,05Ã ¹50 ÒÀÁ."ÓÐÀËÁÈÎÔÀÐÌ" ÎÀÎ29.87
ÍÈÒÐÎÌÈÍÒ ÀÝÐÎÇÎËÜ ÏÎÄÚßÇ.ÄÎÇÈÐ. 400ÌÊÃ/ÄÎÇÀ 10à ¹1EGIS119.89
ÍÈÒÐÎÑÎÐÁÈÄ ÒÀÁ. 10ÌÃ.¹50"ÔÀÐÌÀÏÎË-ÂÎËÃÀ"5.88
ÍÈÒÐÎÑÎÐÁÈÄ ÒÀÁ. 10ÌÃ.¹50"ÔÀÐÌÀÏÎË-ÂÎËÃÀ"6.25
ÍÈÒÐÎÑÎÐÁÈÄ ÒÀÁ. 10ÌÃ.¹50"ÔÀÐÌÀÏÎË-ÂÎËÃÀ"6.25
ÍÈÒÐÎÔÓÍÃÈÍ Ð-Ð Ä\ÍÀÐ. ÏÐÈÌ 25ÌËIVAX PHARMACEUTICALS S.R.O.32.31
ÍÈÒÐÎÔÓÍÃÈÍ Ð-Ð Ä\ÍÀÐ. ÏÐÈÌ 25ÌËIVAX PHARMACEUTICALS S.R.O.32.33
ÍÈÒÒÈÔÎÐ ÊÐÅÌ 115ÃTEVA169.66
ÍÈÒÒÈÔÎÐ ÊÐÅÌ 115ÃTEVA171.17
ÍÎ-ØÏÀ Ð-Ð Ä/ÈÍ ÀÌÏ 20ÌÃ/ÌË 2ÌË ¹25CHINOIN356.49
ÍÎ-ØÏÀ Ð-Ð Ä/ÈÍ ÀÌÏ 20ÌÃ/ÌË 2ÌË ¹25CHINOIN356.62
ÍÎ-ØÏÀ ÒÀÁ 40ÌÃ ¹60 Ñ ÄÎÇÀÒÎÐ.CHINOIN146
ÍÎ-ØÏÀ ÒÀÁ. 40 ÌÃ ¹ 6CHINOIN37.54
ÍÎ-ØÏÀ ÒÀÁ. 40ÌÃ ¹20CHINOIN73.11
ÍÎ-ØÏÀ ÒÀÁ. 40ÌÃ ¹20CHINOIN73.11
ÍÎ-ØÏÀ ÒÀÁ. 40ÌÃ ¹20CHINOIN73.11
ÍÎ-ØÏÀ ÒÀÁË. 40ÌÃ ¹100CHINOIN168.36
ÍÎ-ØÏÀ ÒÀÁË. 40ÌÃ ¹100CHINOIN168.36
ÍÎ-ØÏÀ ÔÎÐÒÅ ÒÀÁ. 80ÌÃ ¹20CHINOIN98.96
ÍÎ-ØÏÀ ÔÎÐÒÅ ÒÀÁ. 80ÌÃ ¹20CHINOIN98.96
ÍÎ-ØÏÀËÃÈÍ ÒÀÁ. ¹12CHINOIN132.13
ÍÎÂÀÐÈÍÃ ÊÎËÜÖÎ ÂÀÃÈÍ.(ÑÀØÅ) ¹1ORGANON628.05
ÍÎÂÈÃÀÍ ÒÀÁË. Ï/Î ¹20DR.REDDY"S36.29
ÍÎÂÈÍÅÒ ÒÀÁ.Ï/Î ÏËÅÍ.¹21 ¹3GEDEON RICHTER614.72
ÍÎÂÈÍÅÒ ÒÀÁ.Ï/Î ÏËÅÍ.¹21GEDEON RICHTER220.15
ÍÎÂÎ-ÏÀÑÑÈÒ 200 ÌÃ. ÒÀÁ.¹10IVAX PHARMACEUTICALS S.R.O.86.69
ÍÎÂÎ-ÏÀÑÑÈÒ Ð-Ð ÔËÀÊ. 100ÌË.¹1IVAX PHARMACEUTICALS S.R.O.81
ÍÎÂÎ-ÏÀÑÑÈÒ Ð-Ð ÔËÀÊ. 200ÌË ¹1IVAX PHARMACEUTICALS S.R.O.145.91
ÍÎÂÎ-ÏÀÑÑÈÒ ÒÀÁ.Ï/Î ¹30IVAX PHARMACEUTICALS S.R.O.241.91
ÍÎÂÎ-ÏÀÑÑÈÒ ÒÀÁ.Ï/Î ¹60IVAX PHARMACEUTICALS S.R.O.379.25
ÍÎÂÎÊÀÈÍ 5ÌÃ/ÌË 5ÌË ¹10"ÌÎÑÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ" ÔÃÓÏ ÈÌ. Í.À. ÑÅÌÀØÊÎ18.14
ÍÎÂÎÊÀÈÍ 5ÌÃ/ÌË 5ÌË ¹10"ÌÎÑÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ" ÔÃÓÏ ÈÌ. Í.À. ÑÅÌÀØÊÎ18.14
ÍÎÂÎÊÀÈÍ 5ÌÃ/ÌË 5ÌË ¹10"ÌÎÑÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ" ÔÃÓÏ ÈÌ. Í.À. ÑÅÌÀØÊÎ18.16
ÍÎÂÎÊÀÈÍ 5ÌÃ/ÌË 5ÌË ¹10"ÌÎÑÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ" ÔÃÓÏ ÈÌ. Í.À. ÑÅÌÀØÊÎ18.16
ÍÎÂÎÊÀÈÍ Ð-Ð ÀÌÏ. 0,5% 5ÌË ¹10"ÎÐÃÀÍÈÊÀ" ÎÀÎ18.02
ÍÎÂÎÊÀÈÍ Ð-Ð Ä/ÈÍ ÀÌÏ 0,5% 5ÌË ¹10"ÂÈÐÈÎÍ" ÍÏÎ ÔÃÓÏ18.14
ÍÎÂÎÊÀÈÍ Ð-Ð Ä/ÈÍ. 0,5% 200ÌËÝÑÊÎÌ ÍÏÊ ÎÀÎ17.09
ÍÎÂÎÊÀÈÍÀÌÈÄ ÒÀÁ.250ÌÃ ¹20"ÎÐÃÀÍÈÊÀ" ÎÀÎ66.98
ÍÎÃÎÒÊÎÂ ÖÂÅÒÊÈ 35Ã (ÊÀËÅÍÄÓËÛ)"ÔÈÒÎÔÀÐÌ" ÏÊÔ ÎÎÎ11.92
ÍÎÊÑÏÐÅÉ, ÑÏÐÅÉ ÍÀÇÀËÜÍÛÉ 0,5 ÌÃ/ÌË 20 ÌËÑÏÅÐÊÎ ÓÊÐÀÈÍÀ ÑÏ58.63
ÍÎËÈÏÐÅË A ÔÎÐÒÅ ÒÀÁ. Ï/Î 5ÌÃ+1,25ÌÃ ¹30SERVIER/ÑÅÐÄÈÊÑ ÎÎÎ515.39
ÍÎËÈÖÈÍ ÒÀÁË. Ï/Î 400ÌÃ ¹10ÊÐÊÀ-ÐÓÑ/KRKA D.D.76.08
ÍÎËÈÖÈÍ ÒÀÁË. Ï/Î 400ÌÃ ¹20ÊÐÊÀ-ÐÓÑ/KRKA D.D.152.19
ÍÎÎÒÐÎÏÈË Ð-Ð ÀÌÏ. 20% 5ÌË ¹12UCB285.48
ÍÎÐÂÀÑÊ ÒÀÁ. 10ÌÃ ¹14PFIZER390
ÍÎÐÂÀÑÊ ÒÀÁ. 10ÌÃ ¹30PFIZER782.06
ÍÎÐÂÀÑÊ ÒÀÁ. 5ÌÃ ¹14PFIZER218.39
ÍÎÐÂÀÑÊ ÒÀÁ. 5ÌÃ ¹30PFIZER447.25
ÍÎÐÊÎËÓÒ ÒÀÁ.5ÌÃ ¹20GEDEON RICHTER91.56
ÍÎÐÌÀÊÑ ÊÀÏËÈ ÃËÀÇÍÛÅ È ÓØÍÛÅ 0,3% 5ÌË ÔËÀÊ.IPKA LABORATORIES LTD.55.82
ÍÎÐÌÀÊÑ ÒÀÁ.Ï/Î 400ÌÃ ¹6IPKA LABORATORIES LTD.46.48
ÍÎÐÌÎÄÈÏÈÍ ÒÀÁË. 10ÌÃ ¹30GEDEON RICHTER548.45
ÍÎÐÌÎÄÈÏÈÍ ÒÀÁË. 5ÌÃ ¹30GEDEON RICHTER286.64
ÍÓÐÎÔÅÍ ÃÅËÜ 5% 50Ã ÄËß ÍÀÐ. ÏÐÈÌ.RECKITT BENCKISER/BOOTS HEALTHCARE111.52
ÍÓÐÎÔÅÍ ÃÅËÜ 5% 50Ã ÄËß ÍÀÐ. ÏÐÈÌ.RECKITT BENCKISER/BOOTS HEALTHCARE115.63
ÍÓÐÎÔÅÍ ÃÅËÜ 5% ÒÓÁÀ 50Ã ¹1PHARMA SIERRA MANUFACTURING S.L.111.52
ÍÓÐÎÔÅÍ ÑÓÏÏ.ÐÅÊÒ. Ä/ÄÅÒ. 60 ÌÃ ¹10RECKITT BENCKISER76.18
ÍÓÐÎÔÅÍ ÑÓÑÏ. Ä/ÄÅÒ ÔË.100ÌË ÀÏÅËÜÑÈÍRECKITT BENCKISER75.27
ÍÓÐÎÔÅÍ ÑÓÑÏ. Ä/ÄÅÒ ÔË.100ÌË ÊËÓÁÍÈÊÀRECKITT BENCKISER91.33
ÍÓÐÎÔÅÍ ÑÓÑÏ. Ä/ÄÅÒ ÔË.100ÌË ÊËÓÁÍÈÊÀRECKITT BENCKISER92.26
ÍÓÐÎÔÅÍ ÑÓÑÏ. Ä/ÄÅÒ ÔË.100ÌË ÊËÓÁÍÈÊÀRECKITT BENCKISER94.84
ÍÓÐÎÔÅÍ ÒÀÁ. Ï/Î 200ÌÃ ¹24RECKITT BENCKISER79.31
ÍÓÐÎÔÅÍ ÒÀÁË.Ï/Î 200ÌÃ ¹6RECKITT BENCKISER29.96
ÍÓÐÎÔÅÍ ÓËÜÒÐÀÊÀÏ 0,2 ¹10 ÊÀÏÑ.RECKITT BENCKISER89.08
ÍÓÐÎÔÅÍ ÓËÜÒÐÀÊÀÏ ÊÀÏÑ. 0,2 ¹4RECKITT BENCKISER52.48
ÍÓÐÎÔÅÍ ÔÎÐÒÅ 400ÌÃ ÒÀÁË.Ï/Î ¹12RECKITT BENCKISER68.51





2001-2011 http://www.med.sgg.ru - öåíû íà ëåêàðñòâà, ìåäòåõíèêó, âñå äëÿ ñòîìàòîëîãèè, õèðóðãè÷åñêèé è äðóãîé ìåäèöèíñêèé èíñòðóìåíò è òåõíèêà, ôàðìàöåâòè÷åñêèå ïðåïàðàòû è ñóáñòàíöèè îò ïðîèçâîäèòåëåé è îïòîâûõ ïðîäàâöîâ â Ìîñêâå, Ñàíêò-Ïåòåðáóðãå è äðóãèõ ðåãèîíàõ.



Rambler's Top100 Rambler's Top100 Ðåéòèíã@Mail.ru